Delivery Order SPE2DB20D3103-SPE2DB24FM4V2
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,500.00 for the supply of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 31, 2024. This Delivery Order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor and medical supplier to the U.S. government. The $9,882.62 firm fixed-price delivery order is for the provision of 4564478814 - Doxorubicin Liposome 20mg/10ml 10ml, with a completion date of May 3, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- This contract award is for the delivery of Doxorubicin Liposome 50mg/25ml vials to the U.S. Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,500.00 contract has a firm fixed price and an ultimate completion date of February 12, 2024. This is a delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 50 mg/25 mL vials of the chemotherapy drug doxorubicin liposome, with a ceiling value of $2,647.26 and a completion date of July 14, 2025. This is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $1,071.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,560,957,401 units of Doxorubicin 50 mg/25 ml Vial with a fixed-price of $1,071.00 and a completion date of May 17, 2023. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6NSY, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564898430 - Doxorubicin 200 mg/100 ml vials, with a firm fixed price ceiling value of $2,141.85 and a period of performance ending on June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This federal contract award SPE2DB22D1106|SPE2DB25FEJF6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.92 firm fixed-price delivery order is for the supply of 4,567,954,816 units of the pharmaceutical product DOXIL 20 MG/10 ML VIAL 10ML. This contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp also holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Doxil 50 mg/25 ml vials. The order has a potential value of $3,051.42 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution...